Is NCT07304505 recruiting in Chicago, IL?

Yes, NCT07304505 is currently recruiting participants at its Chicago, IL location. This rheumatoid arthritis (ra) clinical trial is actively enrolling qualified participants.

How do I join the rheumatoid arthritis (ra) clinical trial in Chicago?

To join this clinical trial in Chicago, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Chicago clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Rheumatoid Arthritis (RA) Clinical Trial in Chicago, IL

About This Rheumatoid Arthritis (RA) Study in Chicago

The goal of this clinical study is to collect data on the effect of probiotic administration on clinical outcomes in rheumatoid arthritis patients. Participants will: * Have a 6-week daily administration of a probiotic * Collect fecal samples every other day during the first 3 weeks of the study and twice weekly over the last 3 weeks * Visit the clinic at Baseline, Week 3 and Week 6 for checkup and testing

Sponsor: Ancilia Biosciences

Who Can Participate

Inclusion Criteria

Be able to give written informed consent.

Be 18 years or older.

Clinical diagnosis of rheumatoid arthritis (RA) for more than 6 months.

Have been on stable RA treatment for 3 months and are expected to remain on stable RA treatment during the study.

Willing to consume the study product daily for the duration of the study.

Exclusion Criteria

Participants who are pregnant or wish to become pregnant during the study or who are lactating and/or currently breastfeeding.

Participants currently of biological childbearing potential, but not using a continuous effective method of contraception, as outlined below:

Complete abstinence from intercourse two weeks prior to administration of the Study Product, throughout the clinical study, until the completion of follow-up procedures or for two weeks following discontinuation of the Study Product in cases where Participant discontinues the study prematurely. (Participants utilising this method must agree to use an alternate method of contraception if they should become sexually active and will be queried on whether they have been abstinent in the preceding two weeks when they present to the clinic for the final visit).

Has a male sexual partner who is surgically sterilised prior to the Screening Visit and is the only male sexual partner for that Participant.

Sexual partner(s) is/are exclusively female.

Use of acceptable method of contraception, such as a spermicide, mechanical barrier (e.g., male condom, female diaphragm), tubal ligation, or contraceptive pill. The Participant must be using this method for at least one week prior to and one week following the end of the study.

Use of any intrauterine device (IUD) or contraceptive implant. The Participant must have the device inserted at least two weeks prior to the first screening visit, throughout the study, and two weeks following the end of the study.

Has a history of drug and/or alcohol abuse.

Has food allergies or other issues with foods that would preclude intake of the Study Products including milk and soy allergies.

Has any significant acute or chronic coexisting health conditions that would prevent them from fulfilling the study requirements, put the Participant at risk or would confound the interpretation of the study results as judged by the investigator on the basis of medical history and routine laboratory test results. Excluded health conditions include:

history of mixed connective tissue disease or overlap syndrome (Systemic lupus erythematosus (SLE), Systemic sclerosis (scleroderma), Polymyositis/ dermatomyositis)

Prior history or current inflammatory joint disease other than RA (such as psoriatic arthritis, gout, reactive arthritis, Lyme disease).

Diagnosed gastrointestinal disease

Gastrointestinal surgery, excluding cholecystectomy and appendectomy in the last five years.

Renal failure

Liver cirrhosis

Current or recent (in the past 8-weeks) use of a medication that the investigator believes would interfere with the objectives of the study or pose a safety risk or confound the interpretation of the study results. Prohibited medications include: a. Antibiotics

Current or recent (in the past 4-weeks) use of prohibited nutritional or non-nutritional supplements that the investigator believes would interfere with the objectives of the study or pose a safety risk or confound the interpretation of the study results. Prohibited supplements include: a. Probiotics

Current or recent (in the past 2-weeks) use of yoghurts containing probiotics.

Individuals who, in the opinion of the investigator, are considered to be poor attendees or unlikely for any reason to be able to comply with the study.

Participants may not be participating in other clinical studies. If the participant has previously taken part in an experimental study, the Investigator must ensure sufficient time has elapsed before entry to this study to ensure the integrity of the results.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chicago?

Yes, this clinical trial (NCT07304505) has an active research site in Chicago, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Rheumatoid Arthritis (RA) Treatment Options in Chicago, IL

If you're searching for rheumatoid arthritis (ra) treatment options in Chicago, IL, this clinical trial (NCT07304505) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced rheumatoid arthritis (ra) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all rheumatoid arthritis (ra) clinical trials near you to find additional studies recruiting in your area.

Rheumatoid Arthritis (RA) Clinical Trial in Chicago, IL

Expert Care in Chicago

IRB Approved

No-Cost Care

Apply for This Chicago Location

Why Participate?

Simple Process